- Report
- February 2025
- 185 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- January 2025
- 183 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- January 2025
- 183 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- July 2024
- 153 Pages
Global
From €3807EUR$4,250USD£3,245GBP
- Report
- September 2024
- 173 Pages
Global
From €3583EUR$4,000USD£3,054GBP
- Report
- August 2024
- 200 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- May 2025
- 200 Pages
Europe
From €2230EUR$2,490USD£1,901GBP
- Report
- October 2018
- 450 Pages
Global
From €3134EUR$3,499USD£2,672GBP
- Report
- December 2022
- 354 Pages
Global
From €4796EUR$5,542USD£3,950GBP
- Report
- March 2023
- 450 Pages
Global
From €4796EUR$5,542USD£3,950GBP
- Report
- September 2023
- 449 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- July 2022
- 159 Pages
Global
From €2105EUR$2,350USD£1,794GBP
- Report
- September 2020
- 219 Pages
Global
From €3135EUR$3,500USD£2,672GBP
- Report
- July 2020
- 255 Pages
Global
From €3135EUR$3,500USD£2,672GBP
- Report
- September 2023
- 80 Pages
Global
From €5329EUR$5,950USD£4,543GBP

Inhalers and nebulisers are medical devices used to deliver medication to the lungs. Inhalers are handheld devices that deliver medication in the form of a mist or aerosol, while nebulisers are larger machines that deliver medication in the form of a fine mist. Inhalers are the most common form of medication delivery for respiratory conditions such as asthma and COPD.
Inhalers and nebulisers are used by millions of people around the world, and the market for these devices is highly competitive. Companies in the market are constantly innovating to develop new and improved devices that are more effective and easier to use. Many of these devices are now available over the counter, making them more accessible to patients.
The inhaler market is also highly regulated, with governments and health authorities setting standards for the safety and efficacy of these devices. Companies must adhere to these standards in order to remain competitive.
Some of the major companies in the inhaler market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, Merck, and Teva Pharmaceuticals. Show Less Read more